Last update:

Clinical pharmacology news

Since the 21st Century Cures Act passed, FDA approvals have relied on fewer studies

Since the passage of the 21st Century Cures Act in 2016, Food and Drug Administration (FDA) approvals for new medical products have relied on fewer studies, according to a study published Aug. 26, 2026, in the PLOS ONE by ...

Novel molecular shuttle could expand delivery of medicines across the blood–brain barrier

The blood–brain barrier (BBB) is a protective filter that lines the brain's blood vessels and is notoriously hard to penetrate, making the treatment of brain disorders very difficult. Strategies designed to breach the BBB ...

New mRNA immunotherapy eliminates pancreatic tumors in mice

Inspired by the work of the RNA Therapeutics Institute at UMass Chan Medical School and the development of the COVID vaccine, Marcus Ruscetti, Ph.D., and Chaitanya Naimesh Parikh, Ph.D. '26, have developed an immunotherapy ...

Study suggests new antibody therapy for tick-borne disease

Crimean-Congo hemorrhagic fever virus (CCHFV) is a dangerous virus spread by ticks. It transmits Crimean-Congo hemorrhagic fever (CCHF), a serious disease that has been spreading into new regions worldwide. Capable of killing ...

DIY peptide injections are risky

DIY peptide injections, which promise to boost everything from weight loss and muscle-building to longevity and sexual health, are a high-risk wellness fad that keeps growing.

How drugs leach out of your sweat (and can spoil your sofa)

Like all consumer products, sofas come with instructions for how best to use and maintain them. But it may surprise you that many furniture companies warn medicines can seep out in your sweat or body oils and damage your ...

Finding new osteoarthritis medicines via AI and genetics

Osteoarthritis (OA) is a chronic, painful joint disease and a leading cause of disability. Despite its prevalence, therapies for osteoarthritis are limited and focus on symptom management. Now, researchers are combining genetic ...

FDA approves first drug for full range of narcolepsy symptoms

The U.S. Food and Drug Administration has approved Orzeyful (oveporexton) tablets to treat narcolepsy type 1 in adults. Orzeyful marks the first medication approved for the full range of symptoms associated with narcolepsy ...

GLP-1 drug linked to heart benefits for high-risk patients

Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart ...

What's in kratom products? Tests find 85% conflict with labels

What's listed on a kratom product label may not tell the full story. Researchers in the University of Florida College of Pharmacy have found that commercially available kratom products, including many kratom-derived products, ...